MOther-Child Interaction Assessment TRAINING for Pediatricians (MOCITRAINING)

September 30, 2022 updated by: University Hospital, Lille
The originality of the MOCITRAINING study lies in the integration of infant and maternal care during the pediatric consultation and the assessment of the impact of this type of care in the short and medium term on The MOCITRAINING program could contribute to improving the quality of parent-child interactions.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

3504

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Lille, France
        • Recruiting
        • CHU
        • Principal Investigator:
          • Renaud Jardri, MD,PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

3 weeks to 1 month (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Each child will be included WITH his biological mother at the first-month visit after birth.
  • Age: 1 month + / - 15 days (child), accompanied by his biological mother
  • Mother able to read French;
  • Signed consent letter after complete information of parents about the MOCITRAINING study, its principle, advantages and disadvantages.

Exclusion Criteria:

  • Preterm babies.
  • Children from a twin or multiple pregnancy.
  • Children with somatic diagnosis explaining the presence of digestive, sleeping or interactional disorders.
  • Refusal to participate after clear information about the study;
  • Refusal to sign the consent letter;
  • Refusal to be informed of a diagnostic hypothesis;
  • Participants not covered by the Social Security system;
  • Participants incapable of consenting or under legal protection (guardianship or curatorship).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: F+ group (Mocitraining program)
including 8 pediatricians' clusters. F+ pediatricians will attend a specific training focused on mother-child interactions, maternal psychiatric disorders, particularly PND screening and early interventions for non-psychiatric physician.
The program is clinical and psychometric tools for screening for interactions and postpartum psychiatric disorders. The program will expose the existing care arrangements and the different possible orientations of the families according to the identified problem.
Sham Comparator: F- group (usual follow-up)
grouping 8 pediatricians' clusters. They will not receive the initial training on early interactional disorders and PND screening
usual follow-up

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Frequency of pathological Alarm Distress BaBy (ADBB) scores
Time Frame: in 12-month-aged children.
in 12-month-aged children.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Frequency of pathological Alarm Distress BaBy (ADBB) scores
Time Frame: in 4, 9 and 24 month-aged children
in 4, 9 and 24 month-aged children
Frequency of digestive disorders
Time Frame: in 4, 9, 12 and 24 month-aged children
presence/absence of infantile regurgitations and colics
in 4, 9, 12 and 24 month-aged children
Number of daytime sleep hours
Time Frame: in 4, 9, 12 and 24 month-aged children
in 4, 9, 12 and 24 month-aged children
Number of nighttime awakenings
Time Frame: in 4, 9, 12 and 24 month-aged children
in 4, 9, 12 and 24 month-aged children
Scores on maternal self-evaluation scales (Likert scales)
Time Frame: at 12 and 24 months postpartum
Scores on maternal self-evaluation scales (Likert scales) about parent-child relations (Items concerning comfort and pleasure during interactions)
at 12 and 24 months postpartum
Frequency of dyads referred for psychiatric or perinatal psychiatric consultations
Time Frame: in 4, 9, 12 and 24 month-aged children
in 4, 9, 12 and 24 month-aged children
Frequency of maternal psychotropic medication
Time Frame: in 4, 9, 12 and 24 month-aged children
in 4, 9, 12 and 24 month-aged children

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Renaud Jardri, MD, PhD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 2, 2017

Primary Completion (Anticipated)

December 1, 2026

Study Completion (Anticipated)

December 1, 2026

Study Registration Dates

First Submitted

September 28, 2017

First Submitted That Met QC Criteria

September 28, 2017

First Posted (Actual)

October 3, 2017

Study Record Updates

Last Update Posted (Actual)

October 3, 2022

Last Update Submitted That Met QC Criteria

September 30, 2022

Last Verified

September 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2015_04
  • 2016-A00540-51 (Other Identifier: ID-RCB number, ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression, Postpartum

Clinical Trials on MOCITRAINING program

3
Subscribe